Is American Tower Stock Undervalued?
The market action of late has been nothing short of…
Sell
30
JDOC Quote, Financials, Valuation and Earnings
Last price:
$52.32
Seasonality move
:
2.97%
Day range:
$51.91 - $51.91
52-week range:
$50.54 - $63.49
Dividend yield:
5.43%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
--
Avg. volume:
--
1-year change:
-6.57%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$51.91 | -- | -- | -- | $0.33 | 5.43% | -- |
|
AGNG
Global X Aging Population ETF
|
$30.10 | -- | -- | -- | $0.15 | 0.83% | -- |
|
BMED
iShares Health Innovation Active ETF
|
$25.37 | -- | -- | -- | $0.01 | 0% | -- |
|
HART
NYLI Healthy Hearts ETF
|
$30.87 | -- | -- | -- | $0.06 | 1.2% | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
$28.99 | -- | -- | -- | $0.47 | 0.49% | -- |
|
THW
Tekla World Healthcare Fund
|
$11.33 | -- | -- | -- | $0.12 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.988 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 1.018 | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | 1.140 | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | 0.838 | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | 1.482 | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | 0.973 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema GLP-1, Obesity & Cardiometabolic ETF
|
-- | -- | -- | -- | -- | -- |
|
THW
Tekla World Healthcare Fund
|
-- | -- | -- | -- | -- | -- |
JPMorgan Healthcare Leaders ETF vs. Competitors
-
Which has Higher Returns JDOC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About JDOC or AGNG?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Global X Aging Population ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is JDOC or AGNG More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.780, suggesting its less volatile than the S&P 500 by 21.991%.
-
Which is a Better Dividend Stock JDOC or AGNG?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.43%. Global X Aging Population ETF offers a yield of 0.83% to investors and pays a quarterly dividend of $0.15 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or AGNG?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns JDOC or BMED?
iShares Health Innovation Active ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat iShares Health Innovation Active ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- BMEDiShares Health Innovation Active ETF-- -- -- -
What do Analysts Say About JDOC or BMED?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Health Innovation Active ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than iShares Health Innovation Active ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than iShares Health Innovation Active ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 BMEDiShares Health Innovation Active ETF0 0 0 -
Is JDOC or BMED More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Health Innovation Active ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or BMED?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.43%. iShares Health Innovation Active ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. iShares Health Innovation Active ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or BMED?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than iShares Health Innovation Active ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than iShares Health Innovation Active ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while iShares Health Innovation Active ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for iShares Health Innovation Active ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- BMEDiShares Health Innovation Active ETF-- -- -- --
-
Which has Higher Returns JDOC or HART?
NYLI Healthy Hearts ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat NYLI Healthy Hearts ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- HARTNYLI Healthy Hearts ETF-- -- -- -
What do Analysts Say About JDOC or HART?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Healthy Hearts ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than NYLI Healthy Hearts ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than NYLI Healthy Hearts ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 HARTNYLI Healthy Hearts ETF0 0 0 -
Is JDOC or HART More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison NYLI Healthy Hearts ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or HART?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.43%. NYLI Healthy Hearts ETF offers a yield of 1.2% to investors and pays a quarterly dividend of $0.06 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. NYLI Healthy Hearts ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or HART?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than NYLI Healthy Hearts ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than NYLI Healthy Hearts ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while NYLI Healthy Hearts ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for NYLI Healthy Hearts ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- HARTNYLI Healthy Hearts ETF-- -- -- --
-
Which has Higher Returns JDOC or HRTS?
Tema GLP-1, Obesity & Cardiometabolic ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Tema GLP-1, Obesity & Cardiometabolic ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- -
What do Analysts Say About JDOC or HRTS?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema GLP-1, Obesity & Cardiometabolic ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Tema GLP-1, Obesity & Cardiometabolic ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Tema GLP-1, Obesity & Cardiometabolic ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 HRTSTema GLP-1, Obesity & Cardiometabolic ETF0 0 0 -
Is JDOC or HRTS More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema GLP-1, Obesity & Cardiometabolic ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or HRTS?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.43%. Tema GLP-1, Obesity & Cardiometabolic ETF offers a yield of 0.49% to investors and pays a quarterly dividend of $0.47 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Tema GLP-1, Obesity & Cardiometabolic ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or HRTS?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Tema GLP-1, Obesity & Cardiometabolic ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Tema GLP-1, Obesity & Cardiometabolic ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Tema GLP-1, Obesity & Cardiometabolic ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Tema GLP-1, Obesity & Cardiometabolic ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- HRTSTema GLP-1, Obesity & Cardiometabolic ETF-- -- -- --
-
Which has Higher Returns JDOC or THW?
Tekla World Healthcare Fund has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Tekla World Healthcare Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- THWTekla World Healthcare Fund-- -- -- -
What do Analysts Say About JDOC or THW?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tekla World Healthcare Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Tekla World Healthcare Fund, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Tekla World Healthcare Fund.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 THWTekla World Healthcare Fund0 0 0 -
Is JDOC or THW More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tekla World Healthcare Fund has a beta of 0.940, suggesting its less volatile than the S&P 500 by 5.986%.
-
Which is a Better Dividend Stock JDOC or THW?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 5.43%. Tekla World Healthcare Fund offers a yield of 0% to investors and pays a quarterly dividend of $0.12 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Tekla World Healthcare Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or THW?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Tekla World Healthcare Fund quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Tekla World Healthcare Fund's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Tekla World Healthcare Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Tekla World Healthcare Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- THWTekla World Healthcare Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock Overvalued?
The semiconductor company Broadcom Inc. (NASDAQ:AVGO) is having a stellar…
4 Top Dividend Stocks to Buy Now
If you’re looking for steady income, dividend stocks are a…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 39x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 114x
Sell
39
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
87
CEG alert for Jan 11
Constellation Energy [CEG] is up 25.15% over the past day.
Sell
1
MCY alert for Jan 11
Mercury General [MCY] is down 19.87% over the past day.
Buy
84
ATZAF alert for Jan 11
Aritzia [ATZAF] is up 17.63% over the past day.
